retatrutide weight loss trials New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide Phase 3: 60% Achieved

doi: 10.1152/ajpgi.2000.279.3.G561 10 DaileyMJMoranTH

Regular followup and adjustments are essential, and providers should set realistic expectations with patients from the outset

Information available to date on the use of GLP1-RAs during lactation is limited to one study which included eight women on weekly semaglutide

Managing and Reducing Diarrhoea During Treatment When to Seek Medical Advice About Diarrhoea Alternative Weight Loss Options and Considerations Scientific References Frequently Asked Questions Understanding Weight Loss Injections and Gastrointestinal Side Effects Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for obesity management in the UK

2023 Sep;119:109404